ClearPoint Neuro, Inc.
CLPT
$11.26
$0.010.09%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 8.49M | 7.77M | 8.12M | 7.86M | 7.64M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 8.49M | 7.77M | 8.12M | 7.86M | 7.64M |
| Cost of Revenue | 3.35M | 3.01M | 3.28M | 2.87M | 3.11M |
| Gross Profit | 5.13M | 4.76M | 4.85M | 4.99M | 4.53M |
| SG&A Expenses | 7.92M | 7.03M | 6.70M | 6.61M | 6.12M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 14.65M | 13.38M | 13.29M | 12.60M | 11.86M |
| Operating Income | -6.16M | -5.60M | -5.17M | -4.74M | -4.22M |
| Income Before Tax | -6.01M | -5.39M | -4.97M | -4.41M | -4.13M |
| Income Tax Expenses | 18.00K | -- | -- | -- | 15.00K |
| Earnings from Continuing Operations | -6.03M | -5.39M | -4.97M | -4.41M | -4.15M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6.03M | -5.39M | -4.97M | -4.41M | -4.15M |
| EBIT | -6.16M | -5.60M | -5.17M | -4.74M | -4.22M |
| EBITDA | -6.06M | -5.36M | -4.91M | -4.51M | -3.97M |
| EPS Basic | -0.22 | -0.20 | -0.18 | -0.16 | -0.16 |
| Normalized Basic EPS | -0.14 | -0.12 | -0.11 | -0.10 | -0.10 |
| EPS Diluted | -0.22 | -0.20 | -0.18 | -0.16 | -0.16 |
| Normalized Diluted EPS | -0.14 | -0.12 | -0.11 | -0.10 | -0.10 |
| Average Basic Shares Outstanding | 27.72M | 27.59M | 27.59M | 27.47M | 25.45M |
| Average Diluted Shares Outstanding | 27.72M | 27.59M | 27.59M | 27.47M | 25.45M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |